Premium
CNS Pharmaceuticals Inc (CNSP)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of ... CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0025 | 2.12765957447 | 0.1175 | 0.1627 | 0.1031 | 99546337 | 0.11773137 | CS |
| 4 | 0.0164 | 15.8301158301 | 0.1036 | 0.1627 | 0.0978 | 28974521 | 0.11700257 | CS |
| 12 | -0.004 | -3.22580645161 | 0.124 | 0.3699 | 0.0957 | 25218615 | 0.12957126 | CS |
| 26 | -0.95 | -88.785046729 | 1.07 | 1.65 | 0.0955 | 13601278 | 0.15713159 | CS |
| 52 | -56.38 | -99.7876106195 | 56.5 | 57.5 | 0.0955 | 7515732 | 0.63256522 | CS |
| 156 | -1098.93 | -99.9890814795 | 1099.05 | 1245 | 0.0955 | 3032899 | 45.72211325 | CS |
| 260 | -6659.88 | -99.9981981982 | 6660 | 8430 | 0.0955 | 2060776 | 438.83332582 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
